The U.S. may be further into Delta surge than it appears
Just how far along into the latest Delta variant-fueled coronavirus surge is the United States? No one knows for sure, but former Food and Drug Administration Commissioner Scott Gottlieb is hopeful the country can "turn a corner" in just two or three weeks, he told CBS News' John Dickerson on Sunday's edition of Face the Nation.
There's a couple of reasons behind the relatively optimistic outlook. For starters, Gottlieb, who has criticized the Centers for Disease Control and Prevention's wide-ranging forecasts for the current wave, believes it's likely there are a lot of mild or subclinical infections in the U.S., which means the number of cases picked up by testing is probably an underestimate of the virus' actual spread. He's also looking across the pond to the United Kingdom, where cases appear to be trending downward again after rising for several weeks. The U.K., Gottlieb noted, has been a few weeks ahead of the U.S. so far and could serve as a sneak preview of the national trajectory.
FiveThirtyEight's Nate Silver also thinks it's worth paying attention to the U.K., as well as India, where the Delta variant originated. Their most recent waves were big ones, but they did appear to turn around quite quickly.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Of course, the U.K. needs to show that it can sustain its recent drop, and either way, the U.S. will likely have a less cohesive path out of the latest wave given the disparate vaccination rates across the country.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Property turns a corner
The outlook for the housing market is starting to look up as rates fall and confidence returns, according to Strutt & Parker.
By Sponsored Content Published
-
What happens when a pope dies?
In The Spotlight Vatican protocol on a pontiff's death is steeped in tradition and ritual
By Chas Newkey-Burden, The Week UK Published
-
Ukrainian election: who could replace Zelenskyy?
The Explainer Donald Trump's 'dictator' jibe raises pressure on Ukraine to the polls while the country is under martial law
By Sorcha Bradley, The Week UK Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published